Atlas Trials

Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants

Clinical trial NCT02448004 · COMPLETED

Trial details

NCT number
NCT02448004
Sponsor
Janssen Cilag N.V./S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-05-11
Primary completion
2015-06-24
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.